Company news
LongBio Pharma (Suzhou) Co., Ltd. news
Latest news releases, newest first.
Articles of Association
October 30, 2026
Poll results of the extraordinary general meeting held on October 30, 2026
October 30, 2026
Voluntary announcement topline data from the phase II clinical trial in China of LP-005 for the treatment of PNH
October 21, 2026
Form of proxy for use by shareholders at the 2026 EGM (or any adjournment thereof) to be held at 4: 00 p.m. on Friday, October 30, 2026
October 9, 2026
Notice of extraordinary general meeting
October 9, 2026
Proposed amendments to the articles of association and notice of extraordinary general meeting
October 9, 2026
Proposed amendments to the articles of association
October 9, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 7, 2026
2026 Interim report
September 22, 2026
Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA
September 14, 2026
Voluntary announcement a phase III clinical trial of LP-003 for the indication of seasonal AR met primary endpoints
June 11, 2026